Skip to main content

CORRECTION article

Front. Oncol., 09 January 2025
Sec. Thoracic Oncology
Volume 14 - 2024 | https://doi.org/10.3389/fonc.2024.1543813

Corrigendum: Modeling extracellular matrix through histo-molecular gradient in NSCLC for clinical decisions

This article is a correction to:

  1. Modeling extracellular matrix through histo-molecular gradient in NSCLC for clinical decisions

    1. Read original article
Camila Machado Baldavira*Camila Machado Baldavira1*Tabatha Gutierrez PrietoTabatha Gutierrez Prieto1Juliana Machado-Rugolo,Juliana Machado-Rugolo1,2Jurandir Tomaz de MirandaJurandir Tomaz de Miranda3Lizandre Keren Ramos da SilveiraLizandre Keren Ramos da Silveira3Ana Paula Pereira VelosaAna Paula Pereira Velosa3Walcy Rosolia TeodoroWalcy Rosolia Teodoro3Alexandre Ab&#x;SaberAlexandre Ab’Saber1Teresa TakagakiTeresa Takagaki4Vera Luiza Capelozzi*Vera Luiza Capelozzi1*
  • 1Department of Pathology, Faculty of Medicine, University of São Paulo, São Paulo, Brazil
  • 2Health Technology Assessment Center, Clinical Hospital, Medical School of São Paulo State University, Botucatu, São Paulo, Brazil
  • 3Rheumatology Division of the Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Faculty of Medicine, University of São Paulo, São Paulo, SP, Brazil
  • 4Division of Pneumology, Instituto do Coração (Incor), University of São Paulo Medical School (USP), São Paulo, Brazil

A Corrigendum on
Modeling extracellular matrix through histo-molecular gradient in NSCLC for clinical decisions

By Baldavira CM, Prieto TG, Machado-Rugolo J, de Miranda JT, da Silveira LKR, Velosa APP, Teodoro WR, Ab’Saber A, Takagaki T and Capelozzi VL (2022) Front. Oncol. 12:1042766. doi: 10.3389/fonc.2022.1042766

In the published article, an author name was incorrectly written as “Lizandre Keren Ramos de Oliveira”. The correct spelling is “Lizandre Keren Ramos da Silveira”.

In the published article, the initials used for Lizandre Keren Ramos da Silveir in the Author contributions section was incorrectly written as “LO”. The correct spelling is “LS”.

In the published article, there was an error in the Data availability statement.

The EMPIAR repository has informed us that the transmission electron microscopy images we submitted for deposit will be removed from their database, as they do not store this specific type of microscopy image. We had deposited these images as per the journal’s request when we submitted the article, but unfortunately, this issue has arisen. As the corresponding author, I searched for alternative repositories but was unable to find any suitable options. Nevertheless, in compliance with ethical research standards and best practices, we, the authors, are fully committed to providing any data or analyses conducted during the study upon request from our peers.

“The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: EMPIAR, accession number EMPIAR-11226.”

The correct Data availability statement appears below.

“The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.”

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: lung cancer, extracellular matrix, epithelial-to-mesenchymal transition, WNT signaling pathway, glycosaminoglycans

Citation: Baldavira CM, Prieto TG, Machado-Rugolo J, de Miranda JT, da Silveira LKR, Velosa APP, Teodoro WR, Ab’Saber A, Takagaki T and Capelozzi VL (2025) Corrigendum: Modeling extracellular matrix through histo-molecular gradient in NSCLC for clinical decisions. Front. Oncol. 14:1543813. doi: 10.3389/fonc.2024.1543813

Received: 11 December 2024; Accepted: 16 December 2024;
Published: 09 January 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Baldavira, Prieto, Machado-Rugolo, de Miranda, da Silveira, Velosa, Teodoro, Ab’Saber, Takagaki and Capelozzi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Camila Machado Baldavira, Y2FtaWxhbWFjaGFkb0B1c3AuYnI=; Vera Luiza Capelozzi, dmVyYS5jYXBlbG96emlAZm0udXNwLmJy

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.